#####
Currently, there are 92.89M common shares owned by the public and among those 91.75M shares have been available to trade.
#####
#####
#####
The company’s stock has a 5-day price change of -9.73% and 41.26% over the past three months. THC shares are trading 18.38% year to date (YTD), with the 12-month market performance up to 23.56% higher. It has a 12-month low price of $109.82 and touched a high of $179.91 over the same period. THC has an average intraday trading volume of 1.59 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -9.71%, -7.14%, and 6.90% respectively.
Institutional ownership of Tenet Healthcare Corp (NYSE: THC) shares accounts for 96.68% of the company’s 92.89M shares outstanding.
It has a market capitalization of $14.49B and a beta (3y monthly) value of 1.53. The stock’s trailing 12-month PE ratio is 9.98, while the earnings-per-share (ttm) stands at $15.62. The company has a PEG of 0.84 and a Quick Ratio of 1.63 with the debt-to-equity ratio at 3.51. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.03% over the week and 3.40% over the month.
Earnings per share for the fiscal year are expected to increase by 20.73%, and 5.65% over the next financial year.
#####
Looking at the support for the THC, a number of firms have released research notes about the stock. Wells Fargo stated their Overweight rating for the stock in a research note on May 29, 2025, with the firm’s price target at $195. Robert W. Baird coverage for the Tenet Healthcare Corp (THC) stock in a research note released on April 15, 2025 offered a Neutral rating with a price target of $137. Morgan Stanley was of a view on March 26, 2025 that the stock is Overweight, while TD Cowen gave the stock Buy rating on February 26, 2025, issuing a price target of $175. JP Morgan on their part issued Overweight rating on December 17, 2024.
